| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |